account_balanceBalance Sheet (BS) Summary

Updated: 03/31/20262026 Q1

Total Assets

3.4B EUR

YoY -1.0%

Shareholders' Equity

3.3B EUR

YoY +0.5%

Equity Ratio

96.5%

YoY +1.5pt

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %

200150100500

2025

Balance Sheet Details

Unit: USD

Item

2025

Cash

Cash and Equivalents

Short-term Investments

Net Receivables

Inventory

Other Current Assets

Total Current Assets

87.87M

2.91B

53.20M

22.49M

5.61M

3.08B

Goodwill

Intangible Assets

Property, Plant and Equipment

Property, Plant and Equipment Net

Long-term Investments

Other Assets

Other Non-current Assets

Net Tangible Assets

Non-current Assets Total

Total Assets

0

848,000

80.66M

46.81M

0

198.55M

3.41B

327.06M

3.41B

Accounts Payable

Short-term Debt

Short/Current Long-term Debt

Current Deferred Revenue

Other Current Liabilities

Total Current Liabilities

32.62M

0

32,000

117.50M

152.86M

Long-term Debt

Long-term Debt Total

Capital Lease Obligations

Other Non-current Liabilities

Net Debt

Non-current Liabilities Total

Total Liabilities

0

6.92M

12.60M

-80.95M

17.79M

170.65M

Common Stock

Common Stock Shares Outstanding

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Other Stockholder Equity

Treasury Stock

Total Stockholder Equity

293.94M

65.90M

2.74B

210.58M

-5.64M

0

3.24B

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan

Lakefront Biotherapeutics N.V.

account_balanceBalance Sheet (BS) Summary

Asset & Liability Mix

Equity Ratio Trend (5 Years)

Balance Sheet Details

Unlock Long-Term Balance Sheet Data